Skip to main content
LLM 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

James R. Berenson, MD

Institute for Myeloma and Bone Cancer Research
West Hollywood, California, United States

Dr. James Berenson is the Founder, President & Chief Executive Officer of the Institute for Myeloma and Bone Cancer Research, President of Oncotherapeutics, a contract research organization specializing in oncology, President of James R. Berenson, MD, a clinical practice specializing in caring for patients with plasma cell dyscrasias, and Founder and President of OncoTracker, a biotech company with a focus on cancer diagnostics and therapeutics.

Dr. Berenson has specialized in research related to myeloma and metastatic bone disease both in the basic and clinical areas for more than 35 years. He has been involved in many of the major breakthroughs that have brought new treatments for patients with these diseases resulting in both an improvement in the length and quality of their lives.

After receiving a Bachelor of Science with Distinction from Stanford University, he earned his Doctorate in Medicine from the University of California at San Diego. Dr. Berenson completed his internship and residency in internal medicine at the University of Utah Medical Center and fellowships in hematology/oncology at the University of California at Los Angeles (UCLA). He is certified by the American Board of Internal Medicine in both internal medicine and medical oncology.

Presentation(s):